Evidence map›Paper›PMID 39141227›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Glucocorticoid Receptor-Dependent Binding Analysis Using Chromatin Immunoprecipitation and Quantitative Polymerase Chain Reaction.

Denis Nalbantoglu, Jonathan M Preuss, Sabine Vettorazzi

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Denis NalbantogluInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany. denis.nalbantoglu@uni-ulm.de.ORCID 0000-0002-4551-0173
Jonathan M PreussInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.ORCID 0000-0003-1385-6126
Sabine VettorazziInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany. sabine.vettorazzi@uni-ulm.de.ORCID 0000-0001-8667-9488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ChIP-qPCR offers the opportunity to identify interactions of DNA-binding proteins such as transcription factors and their respective DNA binding sites. Thereby, transcription factors can interfere with gene expression, resulting in up- or downregulation of their target genes. Utilizing ChIP, it is possible to identify specific DNA binding sites that are bound by the DNA-binding proteins in dependence on treatment or prevailing conditions. During ChIP, DNA-binding proteins are reversibly cross-linked to their DNA binding sites and the DNA itself is fragmented. Using bead-captured antibodies, the target proteins are isolated while still binding their respective DNA response element. Using quantitative PCR, these DNA fragments are amplified and quantified. In this protocol, DNA binding sites of the glucocorticoid receptor are identified by treatment with the synthetic glucocorticoid Dexamethasone in murine bone marrow-derived macrophages.

Indexed as

Chromatin ImmunoprecipitationReceptors, GlucocorticoidAnimalsBinding SitesDexamethasoneDNADNA-Binding ProteinsMacrophagesMiceProtein BindingReal-Time Polymerase Chain ReactionDexamethasoneDNADNA-Binding ProteinsReceptors, GlucocorticoidChromatin immunoprecipitation (ChIP)Co-factorDexamethasoneGlucocorticoid receptor (GR)Immune systemMacrophagePolymerase chain reaction (PCR)Protein–protein interaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.